
CARGO Therapeutics Investor Relations Material
Latest events

Q1 2025
17 Jun, 2025

Q4 2024
17 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CARGO Therapeutics Inc
Access all reports
CARGO Therapeutics Inc. is a clinical-stage biotechnology company dedicated to advancing the next generation of chimeric antigen receptor (CAR) T-cell therapies aimed at cancer treatment. The company is focused on developing transformative CAR T-cell therapies with the mission of outsmarting cancer and delivering more cures for patients globally. By addressing the limitations of currently approved cell therapies, such as limited durability, safety concerns, and unreliable supply, CARGO Therapeutics is working on engineering CAR T-cells with genetic "cargo" designed to enhance the ability to recognize and kill cancer cells.The company is headquartered in San Carlos, California, and its shares are listed on the Nasdaq.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
CRGX
Country
🇺🇸 United States